A groundbreaking medical device promises to transform emergency hemorrhage management. U.S. Patent No. 12295588, titled ‘Adaptable partial circumferential tourniquet’, introduces a versatile solution for controlling severe bleeding in hard-to-reach areas. Developed by Compression Works LLC, this innovation addresses a critical need in trauma care.
A breakthrough in spinal implant technology could reshape recovery for thousands of patients each year. Curiteva, Inc. has been granted U.S. Patent No. 12,263,278 for “Additively manufactured porous polymer medical implants,” marking a significant advancement in 3D-printed medical devices.
May 2025: 1.36% (B+ grade)
April 2025: 1.53% (A+ grade)
Anything over C grade is positive sentiment; anything under C is negative outlook/sentiment. Using that sentiment, it is possible to observe trends over time, and also compare states/countries. In doing so, we can predict which states have the best chance to recover economically from the pandemic (or any other economic incident that may occur).
Anything over C grade is positive sentiment; anything under C is negative outlook/sentiment. Using that sentiment, it is possible to observe trends over time, and also compare states/countries. In doing so, we can predict which states have the best chance to recover economically from the pandemic (or any other economic incident that may occur).
Anything over C grade is positive sentiment; anything under C is negative outlook/sentiment. Using that sentiment, it is possible to observe trends over time, and also compare states/countries. In doing so, we can predict which states have the best chance to recover economically from the pandemic (or any other economic incident that may occur).
Anything over C grade is positive sentiment; anything under C is negative outlook/sentiment. Using that sentiment, it is possible to observe trends over time, and also compare states/countries. In doing so, we can predict which states have the best chance to recover economically from the pandemic (or any other economic incident that may occur).
GreenLab, Inc. has developed a plant-powered breakthrough to fight pollution. U.S. Patent Application No. 20250161732, titled ‘Compositions and methods for degradation of pollutants by plant-produced manganese peroxidase’, outlines a system that uses corn to produce a powerful cleanup enzyme.
A novel approach to cancer immunotherapy has emerged with the development of Mi-2β inhibitors, designed to counteract tumor resistance to immune checkpoint blockade therapies. This innovation is detailed in U.S. Patent No. 12,268,674, titled “Mi-2β inhibitor as an immunotherapy agent,” assigned to BioVentures, LLC. (patents.justia.com)
Australia (AU)
United States
